FDA approves first heart valve designed to grow with children
The FDA has approved the first surgically implanted heart valve designed to be enlarged as a child grows, potentially reducing the need for repeat operations.
The Autus Size-Adjustable Valve is approved for paediatric patients with congenital pulmonary valve disease and can be expanded later using a balloon catheter.
It is also the first US-approved heart valve to use polymeric rather than animal-derived leaflets, introducing a new approach to long-term paediatric valve replacement.
Field | Content |
Article Type | Approvals |
Product | Autus Size-Adjustable Valve |
Regulatory Authority | U.S. Food and Drug Administration |
Approval Type | Medical device approval |
Indication | Paediatric patients with congenital pulmonary valve disease requiring surgical pulmonary valve replacement |
Patient Population | Children with congenital pulmonary valve disease |
Therapy Area | Cardiology; congenital heart disease; paediatric cardiology |
Technology/Modality | Size-adjustable surgically implanted pulmonary heart valve |
Valve Material | Polymeric leaflets |
Geography | United States |
What Happened | The FDA approved the Autus Size-Adjustable Valve for paediatric pulmonary valve replacement. |
Why It Matters | The valve can be enlarged using a balloon catheter as a child grows, potentially reducing the need for repeated open-heart surgery. |
Supporting Context | The device is also the first US-approved heart valve to use polymeric rather than animal-derived leaflets. |
Potential Impact | The technology may reduce lifetime surgical burden for children who would otherwise outgrow fixed-size replacement valves. |
Key Takeaway | The Autus valve is the first FDA-approved heart valve designed to grow with paediatric patients. |
What to Watch | Clinical adoption, long-term durability and real-world evidence on avoidance of repeat surgery. |
Primary Source | U.S. Food and Drug Administration |
Relevant Date | 1 October 2026 |
Discover how nuaxia can support your next medical education initiative:
Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector
Contact us on: support@nuaxia.com
Commentaires